Pace Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.70 Cr
as on 16-11-2024
- Paid Up Capital ₹ 5.97 M
as on 16-11-2024
- Company Age 33 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 66.14%
(FY 2023)
- Profit 29.05%
(FY 2023)
- Ebitda -7.49%
(FY 2023)
- Net Worth 26.19%
(FY 2023)
- Total Assets 21.95%
(FY 2023)
About Pace Biotech
The Corporate was formerly known as Karlo Resources And Credit Pvt Ltd. The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.70 Cr and a paid-up capital of Rs 5.97 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Agrawal, Archana Agrawal, and Kailash Agarwal serve as directors at the Company.
- CIN/LLPIN
U24233WB1991PTC053485
- Company No.
053485
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Nov 1991
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pace Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Agrawal  | Whole-Time Director | 30-Mar-2023 | Current |
| Archana Agrawal | Director | 28-Oct-2002 | Current |
| Kailash Agarwal | Director | 10-Oct-2008 | Current |
Financial Performance of Pace Biotech.
Pace Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 66.14% increase. The company also saw a substantial improvement in profitability, with a 29.05% increase in profit. The company's net worth Soared by an impressive increase of 26.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pace Biotech?
Unlock access to Pace Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Indivac Healthcare Private LimitedActive 12 years 2 monthsAmit Agrawal and Kailash Agarwal are mutual person
- Gochem Speciality Chemicals Private LimitedActive 3 years 5 months
Amit Agrawal and Kailash Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pace Biotech?
Unlock and access historical data on people associated with Pace Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pace Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pace Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
